Login

Member Login

Join

OpenAnesthesia

International Anesthesia Research Society

  • ABA Keywords
    • ITE Keywords
    • MOCA Keywords
  • Expert Voices
    • Article of the Month
    • Ask the Expert
    • Keys to the Cart
    • OA/SPA Pediatric Anesthesia Virtual Grand Rounds
    • Virtual Obstetric Grand Rounds
    • SOAP Obstetric Anesthesia Podcast
    • OA/SPA Ask the Expert Podcast
  • TEE Forum
    • TEE Rounds
    • Basic Course in TEE
  • Subspecialty
    • Cardiac Anesthesia
    • Critical Care and Perioperative Medicine
    • Global Health
    • Neuroanesthesia
    • Obstetric Anesthesia
    • Pain Medicine
    • Pediatric Anesthesia
    • Regional Anesthesia
  • Encyclopedia
  • Our Apps
    • SelfStudyPLUS
    • SelfStudyQbank
    • Nurse Anesthesia
  • Join SelfStudyPLUS
For the most updated list of ABA Keywords and definitions go to https://selfstudyplus.openanesthesia.org/kw
Home / ABA Keyword Categories / Carcinoid syndrome

Carcinoid syndrome

Definition

Background

Carcinoid tumors typically secrete excessive amounts of the hormone serotonin (although they may secrete many hormones). They arise from neuroendocrine cells throughout the body. Most commonly from organs derived from the primitive gut (90% come from distal ileum or appendix).

Serotonin causes vasodilation, increased blood clotting (stimulation of platelet aggregation).

It should be noted that because the vasoactive substances contained in enterochromatin cells are cleared from the circulation by the liver, carcinoid tumors that are isolated to the gastrointestinal tract usually do not result in the systemic manifestations of the carcinoid syndrome.  Thus, Malignant Carcinoid Syndrome typically occurs when tumor spreadsto the liver and beyond – vasoactive substances escape hepatic degradation, excessive production of serotonin both lead to red hot flushing of face, severe and debilitating diarrhea, and asthma attacks (tachykinins).

Surgical Treatment

May offer complete and permanent cure

  • Hepatic resection for accessible areas of liver
  •  Distal ileum – Right hemicolectomy
  •  Appendix – Tumors < 1.5 cm appendectomy
  •  Rectum – <1.5 cm local resection, >1.5 cm abdominoperineal resection
  •  Chemoembolization of liver lesions

 

Anesthetic Considerations

History

  • Some develop right heart problems due to tricuspid stenosis from serotonin action
  • Other common problems – Asthma, wheezing, palpitations, hypotension, dizziness

 

Physical

  • Pay attention to: heart murmur, asthma-like symptoms, pellagra, electrolyte deficieny/dehydration from diarrhea, hepatomegaly (from metastasis)
  •  Carcinoid heart disease
  •  Typically right side of heart
  •  Fibrous deposits on valvular endocardium
  •  Thickening of endocardium of cardiac chambers

 

Labs

  • Measurement of serotonin metabolite 5-HIAA in 24 hr urine
  •  25 mg/day of 5-HIAA is diagnostic

 

Goals

Prevention of Mediator release

  • Preoperative Stress (use anxiolytic without histamine relating properties
  •  Response to intubation
  •  Inadequate analgesia
  •  Hypotension / Hypertension
  •  Intraoperative handling of tumor
  •  Histamine releasing drugs (probably should be avoided in patients with carcinoid tumors, although these drugs have been used frequently in the past without complications)

 

Diagnosis

    • Severe hypotension/hypertension

 

    • Flushing

 

    • Bronchospasm

 

    • Hypercoagulability

 

Treatment

    • Octreotide (Somatostatin) immediately available– high affinity for somatostatin receptor that may help relieve vasoactive symptoms and restore hemodynamic stability

 

    • Ondansetron – Anti-serotonin action with potential benefit

 

    • Immediate availability of vasopressors (phenylephrine), vasodilators

 

Although phenylephirne can be used safely in these patients, beta-adrenergic agents such as epinephrine can stimulate the release vasoactive hormones from the tumor and exacerbate hypotension.  It should be noted that the action of beta-adrenergic agents can be blunted if the patient has received an adequate dose of octreotide.   Nevertheless, the primary treatment for hypotension in patients with carcinoid syndrome should be IV fluids, ocreotide, and phenylephrine (if necessary).  The use of beta-adrenergic agents should be reserved for situations when the cause of hypotension is unrelated to the tumor.  They should always be used cautiously.

Note: consider invasive monitoring

Similar keyword: Carcinoid syndrome Sx

 

Subspecialty

General

Related Media

Keyword history

66%/2015

See Also:

Carcinoid crisis: treatment

Similar Keyword:

Carcinoid syndrome dx

Sources

PubMed

Filed Under: ABA Keyword Categories, Advanced, C, Clinical - Endocrine/Metabolic, Subspecialty: General

IARS - International Anesthesia Research Society logo

  • Contact Us
  • About Us
  • Privacy Policy

Connect with Us

Facebook   Twitter   LinkedIn   iTunes  

OpenAnesthesia™ content is intended for educational purposes only and not intended as medical advice.

Reuse of OpenAnesthesia™ content for commercial purposes of any kind is prohibited.

Copyright © 2019